Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.08 +0.06 (+2.97%)
At close: Oct 2, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Cash & Equivalents (2024 - 2026)

Updated

Polaryx Therapeutics (PLYX) posted Cash & Equivalents of $11.54 million for Q2 2026, up 274.7% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Polaryx Therapeutics' Cash & Equivalents came in at $5.14 million, up 11.3% from FY2024.

  • In prior years, Polaryx Therapeutics' Cash & Equivalents was $4.62 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Polaryx Therapeutics 103.68 Mn 79.29 Mn - 11.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.54 Mn
Mar 31, 2026 3.08 Mn
Dec 31, 2025 5.14 Mn
Dec 31, 2024 4.62 Mn
API Access

Polaryx Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLYX&period=max&api_key=YOUR_API_KEY